IQV Stock Analysis: Buy, Sell, or Hold?
IQV - IQVIA Holdings Inc.
$170.43
2.62 (1.56%)
▲
5d:
-4.46%
30d:
+1.43%
90d:
+2.08%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 28, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.7/10
Get Alerted When IQV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IQV trading at deep discount. Market pricing in -5.4% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: IQV trading at deep discount. Market pricing in -5.4% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$283.66
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$176.13
3.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IQV is currently trading at $170.43, which is considered oversold relative to its 30-day fair value range of $168.92 to $183.57. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.8) compared to its historical average (14.0). Remarkably, the market is currently pricing in an annual earnings decline of 5.4% over the next few years. This pessimistic expectation contrasts with the company's recent 15.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $163.01, while resistance sits at $190.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $225.47 (+34.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $163.01, while resistance sits at $190.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $225.47 (+34.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$168.92 -
$183.57
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.4% below Wall St target ($225.47)
Trading Range Analysis
30-Day Trading Range
$168.92 -
$183.57
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$163.02
Resistance Level
$190.68
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.82
Wall Street Target
$225.47
(+34.4%)
Revenue Growth (YoY)
8.4%
Earnings Growth (YoY)
15.0%
Profit Margin
8.3%
Valuation Discount vs History
-5.4% cheaper
PE vs Historical
11.8 vs 14.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.4%
(market-implied from PE analysis)
1-Year Target
$158.75
(-5%)
2-Year Target
$150.18
(-11%)
3-Year Target
$142.07
(-15%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$168.26
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.8%)
$420.62
(+151%)
Base:
(SPY PE: 11.8, Growth: 10.8%)
$228.27
(+36%)
Bear:
(PE: 10.0, Growth: 10.8%)
$194.03
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 20.73 | Current EPS (TTM): $8.05
Bull Case
$323.72
(+93%)
Analyst growth 76.4%, PE expands to 22.8
Base Case
$294.29
(+75%)
Market implied 76.4%, PE stable at 20.7
Bear Case
$113.47
(-32%)
Severe decline -20.0%, PE contracts to 17.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.8 to 14.0
Stabilization Target:
$198.76
(+18.4%)
PE Expansion Potential:
+18.4%
Share & Embed Analysis
Last updated: June 23, 2026 10:19 AM ET
Data refreshes hourly during market hours. Next update: 11:19 AM
Data refreshes hourly during market hours. Next update: 11:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IQV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Hern
SELL
2026-03-16
Ro Khanna
SELL
2026-02-24
Ro Khanna
SELL
2026-01-29
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
Advanced IQV Option Strategies
Professional options setups generated by AI based on today's IQV price and gamma walls.
